Laboratory animal models are important tools for the identification of avirulent herpes simplex virus type 1 (HSV-1) strains which have potential for use in humans as vaccine strains or gene therapy vectors. We have studied an HSV-1 17 + variant, 1716, that has a deletion in the y34.5 gene and which replicates poorly in the footpads of mice and is unable to grow in the mouse central nervous system or dorsal root ganglia (DRG) of the peripheral nervous system following peripheral inoculation. However, 1716 is known to be capable of establishing latent infections in the DRG of mice. Here we show that 1716 is avirulent after ocular infection and has low virulence after intracranial inoculation in SCID mice. Since SCID mice are much more sensitive to HSV-1 infection than immunocompetent mice, our results clearly demonstrate the drastically reduced virulence of the variant 1716 and provide additional support for the hypothesis that this variant would be avirulent in humans.
Laboratory animal models are important tools for the identification of avirulent herpes simplex virus type 1 (HSV-1) strains which have potential for use in humans as vaccine strains or gene therapy vectors. We have studied an HSV-1 17 + variant, 1716 , that has a deletion in the y34.5 gene and which replicates poorly in the footpads of mice and is unable to grow in the mouse central nervous system or dorsal root ganglia (DRG) of the peripheral nervous system following peripheral inoculation. However, 1716 is known to be capable of establishing latent infections in the DRG of mice. Here we show that 1716 is avirulent after ocular infection and has low virulence after intracranial inoculation in SCID mice. Since SCID mice are much more sensitive to HSV-1 infection than immunocompetent mice, our results clearly demonstrate the drastically reduced virulence of the variant 1716 and provide additional support for the hypothesis that this variant would be avirulent in humans.
Testing the virulence of herpes simplex virus type 1 (HSV-1) deletion mutants in the mouse model is an important tool for the identification of the genes that play a role in HSV-I pathogenesis. HSV variants deleted in the y34.5 gene are impaired in their replication in peripheral tissues and fail to replicate in the peripheral and central nervous systems of mice following footpad, corneal or vaginal inoculation (Robertson et al., 1992; Whitley et al., 1993) . Such mutants establish latent infections in the peripheral nervous system, albeit inefficiently (Robertson et al., 1992) . Following intracerebral (i.c.) inoculation ~34.5 mutants are almost totally avirulent (LDs0 approx. 107 p.f.u./mouse; Chou et al., 1990; MacLean et al., 1991 ; Taha et aL, 1990) . The reason for the drastically reduced virulence of 734.5 mutants in mice is presently unclear. It has been proposed that the 734.5 protein interferes with the shutoff of protein synthesis and the induction of programmed cell death in infected neurons. This would enable the expression of virus proteins and completion of the replication cycle in these cells (Chou & Roizman, 1992) . Mutations in the y34.5 gene may affect as yet undiscovered viral functions associated with the minor latency-associated transcript (LAT) (transcribed from the DNA strand opposite to y34.5; Mitchell et aL, 1990) and/or with other, recently reported transcripts antisense to the 734.5 gene (Yeh & Schaffer, 1993 ; Bohenzky et al., 1993) . Owing to the drastically reduced virulence of y34.5 gene variants in mice, these variants are viewed as promising vaccine strains and gene therapy vector candidates.
Recent experimental evidence shows that SCID mice (Bosma et al., 1983) , deficient in their T and B cell functions, are much more sensitive to HSV-1 infection than immunocompetent mice (Minagawa et al., 1988) . HSV-1 variants that are avirulent in immunocompetent mice may still establish infections that are productive, persistent, and eventually lethal in SCID mice (Valyi-Nagy et al., 1992 . Accordingly, HSV-1 infection of SCID mice provides an animal model with increased sensitivity for the evaluation of the virulence of HSV-1 mutants (Valyi-Nagy et al., 1992 .
The work presented here was undertaken to test the virulence of the 734.5 variant 1716 in the SCID mouse model. Following ocular infection of SCID mice (Bosma et al., 1983) with 1-6 x 107 p.f.u./eye of 1716 (the highest dose possible with our virus stock) no deaths were noted during a 6 month observation period (Table 1 ). This result is strikingly different from the rapid death of SCID mice (within 2 weeks) following ocular infection with as few as 2 x 102 p.f.u./eye of the wild-type HSV-1 strain 17 +, or at day 44.6 _+ 26 following 2 x 104 p.f.u./eye of the insertion mutant in1814 which fails to make functional trans-inducing factor (Valyi-Nagy et al., 1992) . Our results show that 1716 is also less virulent to SCID mice than the genetically engineered thymidine kinase-nega- NA 0"00 NA 0"00 4 * All results were calculated as an average of two or three independent experiments. t NA, Not applicable: no mice infected with strain 17 + survive at these times.
tive HSV-1 strain dlsptk (Coen et al., 1989) which kills SCID mice at 80.8 _+ 21.3 days after ocular infection with 2 x 106 p.f.u, of virus .
The eyes and trigeminal ganglia from 1716-infected SCID mice that were sacrificed at selected times postinfection (p.i.) did not contain infectious virus, with the exception of a low level detected at day 1 p.i. (Table 2) . In contrast, wild-type HSV-1 strain 17 + replicated efficiently in both the eyes and trigeminal ganglia of SCID mice and high titres were detected in these tissues up to 7 days p.i. (Table 2) . HSV-1 strain 1716 could not be detected in trigeminal ganglia by explant co-cultivation performed as described by Deatly et al. (1988) at any of the times studied (4 to 60 days p.i.). This sensitive technique can detect small amounts of infectious virus following its growth in either the tissue or the monolayer of susceptible cells. PCR was performed to determine whether the inability to recover HSV-1 strain 1716 from the trigeminal ganglia of the infected SCID mice by virus titration or co-cultivation was due to the lack of 1716 DNA in the ganglia. Two out of four pairs of trigeminal ganglia derived from SCID mice sacrified 50 days p.i. with HSV-1 strain 1716 were found to contain more than 10 copies of HSV-1 DNA (Fig. 1) . In order to determine the pattern of viral gene expression in the trigeminal ganglia of 1716-infected mice, in situ hybridization for the detection of transcripts encoded by HSV-1 genes of four different kinetic classes was performed as previously described (Deatly et al., 1988; Valyi-Nagy et al., 1991 a, b) . Sections of the trigeminal ganglia of immunocompetent BALB/c mice latently infected with strain 17 + (30 days p.i.) and of the trigeminal ganglia of SCID mice acutely infected with 17 + (4 days p.i.) were used as positive control tissues (Table 3) . Tissue sections of trigeminal ganglia derived from SCID mice 21, 30 and 180 days p.i. with HSV-1 strain 1716 were found to contain cells positive for the LATs (Fig. 2) ; a few cells positive for transcripts derived from the ICP27 and glycoprotein C genes (belonging to the ~ and Y2 kinetic classes, respectively) were also detected (Table 3) . Trigeminal ganglion sections derived from 1716-infected SCID mice 21 days p.i. were also reacted with polyclonal HSV-1 antisera by indirect immunohistochemistry as previously described and were found to be negative for viral antigens.
The reduced virulence of strain 1716 was further demonstrated by experiments involving intracranial (i.c.) infection. Whereas i.c. inoculation of SCID mice with 95 p.f.u, of parental strain 17 + killed all infected animals within 7 days, we found that i.c. inoculation of 9 x 105 p.f.u, of 1716 caused no deaths. Even after the inoculation of 9 x 106 p.f.u, of strain 1716 only two out of five SCID mice died (Table 1) . Thus the i.c. virulence of strain 1716 is at least 100000-fold less than that of strain 17 + in SCID mice. These results are very similar to the findings of a previous study in which immunocompetent mice were inoculated i.c. with strain 17 + or strain 1716 (MacLean et al., 1991) .
Our results show that following ocular infection, HSV-1 strain 1716 did not replicate, or replicated only extremely inefficiently, in the eyes of SCID mice. Some virus, however, was transported to the trigeminal ganglia, where viral replication was also completely, or almost completely, blocked. As SCID mice lack T and B lymphocytes the drastically reduced efficiency of 1716 replication in these mice was probably due to the impaired capacity of this viral strain to replicate in corneal and trigeminal ganglion tissues. The detection of viral immediate early (ICP27) and late (gC) gene expression throughout the studied timecourse of HSV-1 strain 1716 infection shows that 1716 infection in SCID mice did not lead to a latent infection in the classical sense, in which by 30 days p.i. viral gene expression is limited to the LATs (reviewed by Fraser & Valyi-Nagy, 1993) . Instead of latency, long-term 1716/SCID mouse interactions could rather be defined as viral persistence associated with no disease or mortality owing to the inherent avirulence of the infecting agent.
We observed virus-specific mRNA but no viral protein expression in the trigeminal ganglia of 1716-infected SCID mice. These results are consistent with the observations of Chou & Roizman (1992) who found that in the absence of the ~34.5 protein viral protein expression is compromised. Hence it seems possible that the replication of 1716 in SCID mouse tissues was blocked at the level of protein expression.
Our finding of significantly impaired 1716 replication in the cornea and trigeminal ganglia of SCID mice and our inability to reactivate strain 1716 from trigeminal ganglia by explant culture suggest that functions of the 734.5 protein are very important for viral replication in these tissues. In footpad and dorsal root ganglion tissues HSV-1 strain 1716 replication (and reactivation) is less compromised (McLean et al., 1991; Robertson et al., 1992) . Such differences in tissue permissiveness for infection by a ~34.5 mutant have been observed by others (Whitley et al., 1993) . In summary, the complete lack of any signs of illness in SCID mice infected with > 10 r p.f.u, strain 1716/eye compared with 100 % mortality with 2 × 102 p.f.u./eye of 17 +, demonstrates that 1716 has virtually no ability to cause disease by the ocular route, and is at least 100000fold less virulent by the i.c. route. As strain 1716 has been found to lack virulence in the sensitive SCID mouse model, our data provide additional support for the hypothesis that this variant would be avirulent in humans. In conclusion, 1716 appears to be a promising prototype for development as a vaccine strain or gene therapy vector.
